MedPath

Comparison of Lower Limb Endovascular Interventions With and Without the EndoNaut Workstation

Completed
Conditions
Peripheral Arterial Disease
Interventions
Procedure: Endovascular procedure
Registration Number
NCT04709991
Lead Sponsor
Therenva
Brief Summary

To demonstrate that the use of EndoNaut for endovascular procedures on the femoropopliteal axis has a clinical impact for the patient (decrease in irradiation and the volume of contrast product) as well as for nursing staff (reduction in irradiation) compared to procedures performed without EndoNaut.

Detailed Description

Peripheral artery disease (PAD) is characterized by a narrowing of the size of arteries, which resulting in a loss of hemodynamic load. Endovascular (or percutaneous) procedures performed at the infrainguinal level (axefemoro-popliteal) are very common in affected patients. Therenva offers a complete and consistent lightweight navigation solution (EndoNaut®) based on artificial intelligence (AI) algorithms, and providing technology accessible to all operating rooms for PAD procedures. The aim of this study is to demonstrate that the use of EndoNaut for endovascular procedures on the femoropopliteal axis has a clinical impact for the patient (decrease in irradiation and the volume of contrast product) as well as for nursing staff (reduction in irradiation) compared to the procedures performed by EndoNaut.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Patients with peripheral arterial disease of the lower limbs, all clinical stages, lesions of the femoro-popliteal stage and candidates for endovascular treatment of these lesions.
  • Major patients
  • Patients not opposed to their participation in the study
Exclusion Criteria
  • Patients requiring conventional surgical revascularization.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Procedures with EndoNautEndovascular procedure-
Procedures without EndonautEndovascular procedure-
Primary Outcome Measures
NameTimeMethod
Volume of contrast product used during the routine care procedure (ml)1 day At enrollment

Volume are reported in mL

Irradiation parameters: dose-area quantification (mGy/m2)1 day At enrollment

Parameter given by the X-ray imaging device

Irradiation parameters: evaluation of the Fluoroscopy duration (min)1 day At enrollment

Parameter given by the X-ray imaging device

Irradiation parameters: measurement of air Kerma (mGy)1 day At enrollment

Parameter given by the X-ray imaging device

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

CH Libourne

🇫🇷

Libourne, France

© Copyright 2025. All Rights Reserved by MedPath